185 related articles for article (PubMed ID: 24957217)
21. Human ovarian tumour cells can bind hyaluronic acid via membrane CD44: a possible step in peritoneal metastasis.
Gardner MJ; Catterall JB; Jones LM; Turner GA
Clin Exp Metastasis; 1996 Sep; 14(4):325-34. PubMed ID: 8878406
[TBL] [Abstract][Full Text] [Related]
22. Hyaluronan synthesis is required for IL-2-mediated T cell proliferation.
Mahaffey CL; Mummert ME
J Immunol; 2007 Dec; 179(12):8191-9. PubMed ID: 18056362
[TBL] [Abstract][Full Text] [Related]
23. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.
Bourguignon LY; Wong G; Earle C; Krueger K; Spevak CC
J Biol Chem; 2010 Nov; 285(47):36721-35. PubMed ID: 20843787
[TBL] [Abstract][Full Text] [Related]
24. Enhancement of HIV-1 infection and intestinal CD4+ T cell depletion ex vivo by gut microbes altered during chronic HIV-1 infection.
Dillon SM; Lee EJ; Donovan AM; Guo K; Harper MS; Frank DN; McCarter MD; Santiago ML; Wilson CC
Retrovirology; 2016 Jan; 13():5. PubMed ID: 26762145
[TBL] [Abstract][Full Text] [Related]
25. CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion.
Bourguignon LY; Singleton PA; Diedrich F; Stern R; Gilad E
J Biol Chem; 2004 Jun; 279(26):26991-7007. PubMed ID: 15090545
[TBL] [Abstract][Full Text] [Related]
26. Hyaluronic acid-CD44 interaction mediates the adhesion of lymphocytes by amniotic membrane stroma.
Higa K; Shimmura S; Shimazaki J; Tsubota K
Cornea; 2005 Mar; 24(2):206-12. PubMed ID: 15725890
[TBL] [Abstract][Full Text] [Related]
27. Hyaluronan-dependent motility of B cells and leukemic plasma cells in blood, but not of bone marrow plasma cells, in multiple myeloma: alternate use of receptor for hyaluronan-mediated motility (RHAMM) and CD44.
Masellis-Smith A; Belch AR; Mant MJ; Turley EA; Pilarski LM
Blood; 1996 Mar; 87(5):1891-9. PubMed ID: 8634437
[TBL] [Abstract][Full Text] [Related]
28. Hyaluronan-CD44 interaction with Rac1-dependent protein kinase N-gamma promotes phospholipase Cgamma1 activation, Ca(2+) signaling, and cortactin-cytoskeleton function leading to keratinocyte adhesion and differentiation.
Bourguignon LY; Singleton PA; Diedrich F
J Biol Chem; 2004 Jul; 279(28):29654-69. PubMed ID: 15123640
[TBL] [Abstract][Full Text] [Related]
29. CD44 costimulation promotes FoxP3+ regulatory T cell persistence and function via production of IL-2, IL-10, and TGF-beta.
Bollyky PL; Falk BA; Long SA; Preisinger A; Braun KR; Wu RP; Evanko SP; Buckner JH; Wight TN; Nepom GT
J Immunol; 2009 Aug; 183(4):2232-41. PubMed ID: 19635906
[TBL] [Abstract][Full Text] [Related]
30. Tumor necrosis factor-alpha induces functionally active hyaluronan-adhesive CD44 by activating sialidase through p38 mitogen-activated protein kinase in lipopolysaccharide-stimulated human monocytic cells.
Gee K; Kozlowski M; Kumar A
J Biol Chem; 2003 Sep; 278(39):37275-87. PubMed ID: 12867430
[TBL] [Abstract][Full Text] [Related]
31. CD44 signaling through p56lck involves lateral association with CD4 in human CD4+ T cells.
Dianzani U; Bragardo M; Tosti A; Ruggeri L; Volpi I; Casucci M; Bottarel F; Feito MJ; Bonissoni S; Velardi A
Int Immunol; 1999 Jul; 11(7):1085-92. PubMed ID: 10383941
[TBL] [Abstract][Full Text] [Related]
32. CD44 expression and hyaluronic acid binding of malignant glioma cells.
Knüpfer MM; Poppenborg H; Hotfilder M; Kühnel K; Wolff JE; Domula M
Clin Exp Metastasis; 1999 Feb; 17(1):71-6. PubMed ID: 10390150
[TBL] [Abstract][Full Text] [Related]
33. CD44-hyaluronic acid interactions mediate shear-resistant binding of lymphocytes to dermal endothelium in acute cutaneous GVHD.
Milinkovic M; Antin JH; Hergrueter CA; Underhill CB; Sackstein R
Blood; 2004 Jan; 103(2):740-2. PubMed ID: 14504094
[TBL] [Abstract][Full Text] [Related]
34. Hyaluronic acid-CD44 interactions promote BMP4/7-dependent Id1/3 expression in melanoma cells.
Wu RL; Sedlmeier G; Kyjacova L; Schmaus A; Philipp J; Thiele W; Garvalov BK; Sleeman JP
Sci Rep; 2018 Oct; 8(1):14913. PubMed ID: 30297743
[TBL] [Abstract][Full Text] [Related]
35. CD44 differentially activates mouse NK T cells and conventional T cells.
Larkin J; Renukaradhya GJ; Sriram V; Du W; Gervay-Hague J; Brutkiewicz RR
J Immunol; 2006 Jul; 177(1):268-79. PubMed ID: 16785522
[TBL] [Abstract][Full Text] [Related]
36. α
Cheung KW; Wu T; Ho SF; Wong YC; Liu L; Wang H; Chen Z
J Virol; 2018 Apr; 92(8):. PubMed ID: 29386290
[TBL] [Abstract][Full Text] [Related]
37. Hyaluronan induces cell death in activated T cells through CD44.
Ruffell B; Johnson P
J Immunol; 2008 Nov; 181(10):7044-54. PubMed ID: 18981124
[TBL] [Abstract][Full Text] [Related]
38. Topical hyaluronidase decreases hyaluronic acid and CD44 in human skin and in reconstituted human epidermis: evidence that hyaluronidase can permeate the stratum corneum.
Laugier JP; Shuster S; Rosdy M; Csóka AB; Stern R; Maibach HI
Br J Dermatol; 2000 Feb; 142(2):226-33. PubMed ID: 10730753
[TBL] [Abstract][Full Text] [Related]
39. Cutting edge: high molecular weight hyaluronan promotes the suppressive effects of CD4+CD25+ regulatory T cells.
Bollyky PL; Lord JD; Masewicz SA; Evanko SP; Buckner JH; Wight TN; Nepom GT
J Immunol; 2007 Jul; 179(2):744-7. PubMed ID: 17617562
[TBL] [Abstract][Full Text] [Related]
40. Characterization of CD44-mediated hyaluronan binding by renal tubular epithelial cells.
Oertli B; Fan X; Wüthrich RP
Nephrol Dial Transplant; 1998 Feb; 13(2):271-8. PubMed ID: 9509434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
